Latest / Stock Movers / Fresnillo AstraZeneca Climbs, Argenx Surges
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Well, let's take a look at some of the stocks
- 0:18Speaker 3: on the move today in Europe. I'm to you Adabai
- 0:21Speaker 3: alongside Stephen Carroll, and we're joined by Bloomberg's Breaking News
- 0:24Speaker 3: editor Louise Moon. Luise give morning. Let's start with a
- 0:28Speaker 3: look at British mining companies, and there's a boost for Fresnillo.
- 0:32Speaker 1: Tell us why yes, Fresnillo, And really across the boards,
- 0:35Speaker 1: we've got glen Core, Anglo American, Antofagasta all among the
- 0:38Speaker 1: biggest scalers on the foot seat one hundred this morning.
- 0:41Speaker 1: So miners across the board rising twofold copper is rising
- 0:45Speaker 1: towards record highs. There's a lot of competition for supply. Essentially,
- 0:49Speaker 1: there has been a massive inflow into the US in
- 0:51Speaker 1: anticipation of a tariff decision from Trumps. That's leaving less
- 0:54Speaker 1: supply elsewhere. And gold is also rising, so that's obviously
- 0:58Speaker 1: helpful for precious metal miners like Fresnelo that you mentioned.
- 1:03Speaker 1: It's standing a two week gain, and that's partly thanks
- 1:06Speaker 1: to a weeker dollar a week of US dollar, So
- 1:09Speaker 1: overall strong performance for miners, and they have quite an
- 1:12Speaker 1: outsized influence on the Footsie hundred, so boosting the foots
- 1:15Speaker 1: hundred more generally as well.
- 1:17Speaker 2: Okay. I Meanwhile, Astra Zeneca's share is also on the rise.
- 1:19Speaker 2: There's a stuge to some news about a clinical trial.
- 1:22Speaker 1: Yeah, they had three sets of news this morning, so
- 1:25Speaker 1: I'll start off with the negative.
- 1:26Speaker 2: Okay.
- 1:27Speaker 1: So they're stopping a trial of a experimental cancer drug.
- 1:31Speaker 1: So they're saying it didn't look set to fight lung
- 1:33Speaker 1: cancer better than therapies already exist, and that's a bit
- 1:37Speaker 1: of a setback. Essentially, the CEO, Pascal saw It has
- 1:40Speaker 1: been turning Ash into a bit of a cancer powerhouse.
- 1:44Speaker 1: This one had already been described by Jeffreys as a
- 1:46Speaker 1: bit of a long shot, so slight setback. They're also
- 1:49Speaker 1: a bit more pressure following negative reactions from potential tie
- 1:52Speaker 1: up talks with Bristol Mayers SQUIB earlier this month. Shares
- 1:55Speaker 1: obviously fell on that news and then rose when it
- 1:58Speaker 1: was said that it wasn't going to be or the
- 1:59Speaker 1: talks no longer happening. So slightly a bit more pressure
- 2:03Speaker 1: there for the CEO, but as I say, not all
- 2:06Speaker 1: bad news. They had two other sets of trials published today,
- 2:10Speaker 1: so positive late late stage studies for and already approved
- 2:15Speaker 1: drug to do also with lung cancer. So shares actually rising.
- 2:19Speaker 3: And we're sticking with the broader healthcare biotech space, we
- 2:23Speaker 3: are looking at the Belgian Dutch company our Janks, which
- 2:27Speaker 3: is surging. Can you tell us more about that?
- 2:29Speaker 1: Yes, shares up as much as ten percent. So it
- 2:32Speaker 1: reported its latest large and successful trial for its blockbuster drug.
- 2:38Speaker 1: So this helps patients with an immune system disease. So
- 2:43Speaker 1: at the moment, patients have largely relied on steroids which
- 2:47Speaker 1: can have big side effects, and other immunosuppressants. So this
- 2:50Speaker 1: is quite a big step forward in the space. Bloomberg
- 2:53Speaker 1: Intelligence saying that these results this morning could be the
- 2:56Speaker 1: basis for approval of this drug in the US. So
- 2:58Speaker 1: shares rising.
- 2:59Speaker 2: Other the stockmovers report from Bloomberg Radio. Check back with
- 3:05Speaker 2: us throughout the day for the latest roundup of companies
- 3:07Speaker 2: making news on Wall Street and for the latest market
- 3:10Speaker 2: moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube,
- 3:15Speaker 2: Bloomberg dot com and on Applecarplay and Android Auto with
- 3:18Speaker 2: the Bloomberg Business App